StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) stock

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.60−0.15 (-1.54%)

Close on Nov 17, 2026Market cap $635.26MP/E –Yield –

Bicara Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Bicara Therapeutics's market cap was $694.25M on Nov 11, 2026, against $1.01B a year earlier. Over the last 2 years it ranged from $15.16M to $1.95B, with a median of $886.54M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$694.25M-24.5%
2025Dec 31, 2025$919.13M-3.0%
2024Dec 31, 2024$947.82M–

More Bicara Therapeutics figures

See a number that looks wrong?